Hot topics in cellular neuropathology III: using CRISPR/Cas9 technology for deciphering central nervous system disease targets

Front Cell Neurosci. 2023 Sep 1:17:1276077. doi: 10.3389/fncel.2023.1276077. eCollection 2023.

Author

Dirk M Hermann¹

Affiliation

¹ Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

No abstract available

Keywords: CRISPR/Cas9 technology; gene editing; gene therapy; neurodegenerative disease; neurodevelopment.

Publication types

Editorial